Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy CNS Pharmaceuticals stock | $1.85

Own CNS Pharmaceuticals stock in just a few minutes.

Fact checked

CNS Pharmaceuticals, Inc is a biotechnology business based in the US. CNS Pharmaceuticals shares (CNSP) are listed on the NASDAQ and all prices are listed in US Dollars. CNS Pharmaceuticals employs 3 staff and has a market cap (total outstanding shares value) of USD$45.8 million.

How to buy shares in CNS Pharmaceuticals

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for CNS Pharmaceuticals. Find the stock by name or ticker symbol: CNSP. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until CNS Pharmaceuticals reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$1.85, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of CNS Pharmaceuticals, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of CNS Pharmaceuticals. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

CNS Pharmaceuticals share price

Use our graph to track the performance of CNSP stocks over time.

CNS Pharmaceuticals shares at a glance

Information last updated 2021-01-18.
Latest market closeUSD$1.85
52-week rangeUSD$1.2582 - USD$4.563
50-day moving average USD$2.0997
200-day moving average USD$1.9906
Wall St. target priceUSD$7.5
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-0.2723

Buy CNS Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
$0
Stocks, Forex
$0 + $0.65/contract, $1 minimum
0%
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Public
$0
Stocks, ETFs
N/A
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Titan
Titan
$0
Stocks, Bonds
N/A
1%
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy CNS Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

CNS Pharmaceuticals price performance over time

Historical closes compared with the close of $1.85 from 2021-01-11

1 week (2021-01-14) -1.60%
1 month (2020-12-21) -25.10%
3 months (2020-10-21) 1.09%
6 months (2020-07-21) -3.14%
1 year (2020-01-21) -58.71%
2 years (2019-01-18) N/A
3 years (2018-01-18) N/A
5 years (2016-01-18) N/A

CNS Pharmaceuticals financials

Gross profit TTM USD$0
Return on assets TTM -256%
Return on equity TTM -725.78%
Profit margin 0%
Book value $0.028
Market capitalisation USD$45.8 million

TTM: trailing 12 months

Shorting CNS Pharmaceuticals shares

There are currently 123,867 CNS Pharmaceuticals shares held short by investors – that's known as CNS Pharmaceuticals's "short interest". This figure is 89.7% up from 65,297 last month.

There are a few different ways that this level of interest in shorting CNS Pharmaceuticals shares can be evaluated.

CNS Pharmaceuticals's "short interest ratio" (SIR)

CNS Pharmaceuticals's "short interest ratio" (SIR) is the quantity of CNS Pharmaceuticals shares currently shorted divided by the average quantity of CNS Pharmaceuticals shares traded daily (recently around 3.1 million). CNS Pharmaceuticals's SIR currently stands at 0.04. In other words for every 100,000 CNS Pharmaceuticals shares traded daily on the market, roughly 40 shares are currently held short.

However CNS Pharmaceuticals's short interest can also be evaluated against the total number of CNS Pharmaceuticals shares, or, against the total number of tradable CNS Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case CNS Pharmaceuticals's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 CNS Pharmaceuticals shares in existence, roughly 10 shares are currently held short) or 0.009% of the tradable shares (for every 100,000 tradable CNS Pharmaceuticals shares, roughly 9 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against CNS Pharmaceuticals.

Find out more about how you can short CNS Pharmaceuticals stock.

CNS Pharmaceuticals share dividends

We're not expecting CNS Pharmaceuticals to pay a dividend over the next 12 months.

CNS Pharmaceuticals overview

CNS Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of anti-cancer drug candidates for primary and metastatic cancers of the brain and central nervous system. The company's lead drug candidate is Berubicin, which completed Phase I clinical trial that is used for the treatment of glioblastoma multiforme. It has license agreements with Houston Pharmaceuticals, Inc. and The University of Texas M.D. Anderson Cancer Center; and a development agreement with WPD Pharmaceuticals Inc. CNS Pharmaceuticals, Inc. was founded in 2017 and is based in Houston, Texas.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site